Regional squamous cell carcinomas following systemic sorafenib therapy and isolated limb infusion for regionally advanced metastatic melanoma of the limb

Archives of Dermatology

Volumn 146, Issue 12, 2010, Pages 1438-1439

  Nelson, Kelly Carter ^a   Raymond, Amanda K ^a   Purl, Puja K ^a   Selim, M Angelica ^a   Tyler, Douglas S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; MELPHALAN; SORAFENIB;

AGED; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER RECURRENCE; CANCER SURGERY; CASE REPORT; EXCISION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFUSION; INVASIVE CARCINOMA; ISOLATED LIMB INFUSION; LETTER; LOADING DRUG DOSE; MALE; MELANOMA; PRIORITY JOURNAL; SKIN BIOPSY; SKIN NODULE; SQUAMOUS CELL CARCINOMA; TREATMENT RESPONSE;

AGED; ANTINEOPLASTIC AGENTS; BENZENESULFONATES; CARCINOMA, SQUAMOUS CELL; DRUG ADMINISTRATION ROUTES; FOLLOW-UP STUDIES; HUMANS; LEG; MALE; MELANOMA; NEOPLASM METASTASIS; PYRIDINES; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SKIN NEOPLASMS;

EID: 78650426191     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2010.367     Document Type: Letter

References (2)

1. Beasley GM, Caudle A, Petersen RP, et al. A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US. J Am Coll Surg. 2009;208(5):706-717.
2. Dubauskas Z, Kunishige J, Prieto VG, Jonasch E, Hwu P, Tannir NM. Cutaneous squamous cell carcinoma and inflammation of actinic keratoses associated with sorafenib. Clin Genitourin Cancer. 2009;7(1):20-23.